Trials / Unknown
UnknownNCT02936661
Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 6,700 (estimated)
- Sponsor
- Shanghai First Maternity and Infant Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
It is a multicenter randomized, double-blind and placebo-controlled trial. Totally 6500 women to delivery by cesarean section will be recruited in this study. In addition to routinely oxytocin, the women in study group will receive TXA 1 g in 2 minutes after they delivered their babies, and those in control group will receive placebo. The incidence of postpartum hemorrhage, the amount of bleeding, as well as the side effects will be observed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic Acid | |
| DRUG | Placebo |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2018-12-01
- Completion
- 2019-03-01
- First posted
- 2016-10-18
- Last updated
- 2016-10-18
Source: ClinicalTrials.gov record NCT02936661. Inclusion in this directory is not an endorsement.